Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Imunon, Inc. (CLSN)
|
Add to portfolio |
|
|
|
| Price: |
$1.27
| | Metrics |
| OS: |
9.37
|
M
| |
|
|
| Market cap: |
$11.9
|
M
| |
|
|
|
Net cash:
|
$24
|
M
| |
$2.56
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Revenue growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of goods sold | 0.0 | 0.0 | -23.5 | -24.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.5 | 0.5 | 24.0 | 24.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Gross margin | 100.0% | 100.0% | 4793.1% | 4893.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | | | | | | | | |
| Research and development | 10.6 | 11.3 | 13.1 | 11.9 | 13.1 | 14.6 | 14.7 | 15.0 |
| General and administrative | 10.9 | 7.6 | 8.0 | 9.7 | 5.9 | 6.5 | 6.7 | 8.9 |
| EBITA | -21.0 | -18.5 | -18.2 | -18.7 | -20.8 | -22.1 | -20.8 | -23.3 |
| EBITA margin | -4201.4% | -3697.3% | -3633.1% | -3733.0% | -4152.2% | -4417.6% | -4167.9% | -4664.5% |
| Amortization of intangibles | | | | | 0.2 | 0.0 | 0.0 | 0.0 |
| EBIT | -21.0 | -18.5 | -18.2 | -18.7 | -21.0 | -22.1 | -20.8 | -23.3 |
| EBIT margin | -4201.4% | -3697.3% | -3633.1% | -3733.0% | -4197.7% | -4418.8% | -4169.4% | -4666.0% |
| Pre-tax income | -22.2 | -23.3 | -18.7 | -22.3 | -20.4 | -22.1 | -22.5 | -25.5 |
| Income taxes | -1.4 | -1.8 | -1.8 | -10.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 6.2% | 7.9% | 9.7% | 46.7% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -20.8 | -21.5 | -16.9 | -11.9 | -20.7 | -22.1 | -22.5 | -25.5 |
| Net margin | -4153.9% | -4296.7% | -3370.3% | -2376.7% | -4149.6% | -4410.7% | -4492.2% | -5098.9% |
| |
| Diluted EPS | ($3.83) | ($10.08) | ($0.77) | ($0.68) | ($2.72) | ($11.89) | ($1.03) | ($1.38) |
| Shares outstanding (diluted) | 5.4 | 2.1 | 21.8 | 17.6 | 7.6 | 1.9 | 21.8 | 18.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|